Dec 2, 2019 08:32AM

Nov 20, 2019 05:45PM

Nov 19, 2019 08:30AM

Nov 18, 2019 05:33PM

Nov 18, 2019 05:30PM

Nov 13, 2019 09:31AM

Nov 13, 2019 09:30AM Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program

Nov 7, 2019 05:02PM

Oct 10, 2019 06:12PM

Aug 27, 2019 09:30AM

Jul 31, 2019 09:27AM

Jul 23, 2019 09:32AM

Jul 23, 2019 09:30AM

May 29, 2019 09:25AM Therapix Biosciences Issues Shareholder Update Letter

Feb 14, 2019 07:30AM

Dec 21, 2018 04:12PM

Dec 21, 2018 08:33AM

Dec 21, 2018 08:30AM

Dec 11, 2018 08:30AM

Dec 3, 2018 08:30AM

Nov 29, 2018 04:34PM Therapix Biosciences Clarifies Terms of Recently Issued Convertible Debenture

Nov 27, 2018 08:30AM

Nov 27, 2018 08:30AM

Nov 26, 2018 02:00AM

Oct 30, 2018 08:30AM

Oct 29, 2018 07:30AM

Oct 26, 2018 08:30AM

Oct 24, 2018 06:11AM FSD Pharma Inc. Announces Binding LOI to Acquire Therapix Biosciences (TRPX) for $48M

Oct 24, 2018 06:00AM

Oct 22, 2018 06:16PM

Aug 20, 2018 08:30AM

Jul 12, 2018 08:30AM

Jul 11, 2018 08:57AM

Jul 11, 2018 08:57AM

Nov 2, 2017 08:30AM Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer

Oct 23, 2017 08:30AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All